ARTICLE | Company News
Cellmid, Fujikura Kasei Co. Ltd. deal
February 18, 2013 8:00 AM UTC
Fujikura received an option to license use of Cellmid's midkine ( MDK; MK) diagnostic antibodies on Fujikura's latex-based assay technology. Cellmid will receive an upfront fee and is eligible for an...